Innosys Balance Sheet Health
Financial Health criteria checks 5/6
Innosys has a total shareholder equity of ₩66.4B and total debt of ₩57.0B, which brings its debt-to-equity ratio to 85.8%. Its total assets and total liabilities are ₩232.7B and ₩166.3B respectively. Innosys's EBIT is ₩836.8M making its interest coverage ratio 0.3. It has cash and short-term investments of ₩84.7B.
Key information
85.8%
Debt to equity ratio
₩56.99b
Debt
| Interest coverage ratio | 0.3x |
| Cash | ₩84.75b |
| Equity | ₩66.41b |
| Total liabilities | ₩166.27b |
| Total assets | ₩232.68b |
Financial Position Analysis
Short Term Liabilities: A056090's short term assets (₩197.5B) exceed its short term liabilities (₩158.5B).
Long Term Liabilities: A056090's short term assets (₩197.5B) exceed its long term liabilities (₩7.8B).
Debt to Equity History and Analysis
Debt Level: A056090 has more cash than its total debt.
Reducing Debt: A056090's debt to equity ratio has increased from 5.6% to 85.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A056090 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A056090 has sufficient cash runway for 2.2 years if free cash flow continues to grow at historical rates of 17.5% each year.